(Q39936372)

15 September 2017

title

Persistence of essential fatty acid deficiency in cystic fibrosis despite nutritional therapy (English)

1 reference

essential fatty acid deficiency

15 September 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Luis Aldámiz-Echevarría

1

1 reference

15 September 2017

José Angel Prieto

2

1 reference

15 September 2017

Fernando Andrade

3

1 reference

15 September 2017

Javier Elorz

4

1 reference

15 September 2017

Amaia Sojo

5

1 reference

15 September 2017

Sergio Lage

6

1 reference

15 September 2017

Pablo Sanjurjo

7

1 reference

15 September 2017

Carlos Vázquez

8

1 reference

15 September 2017

Juan Rodríguez-Soriano

9

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

66

1 reference

15 September 2017

issue

5

1 reference

15 September 2017

page(s)

585-589

1 reference

https://scigraph.springernature.com/pub.10.1203/pdr.0b013e3181b4e8d3

15 September 2017

exact match

0 references

cites work

A clinical perspective of cystic fibrosis and new genetic findings: relationship of CFTR mutations to genotype-phenotype manifestations.

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Fatty acid abnormalities in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Current knowledge on fatty acids in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Essential fatty acid deficiency in well nourished young cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Molecular species compositions of lung and pancreas phospholipids in the cftr(tm1HGU/tm1HGU) cystic fibrosis mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Relation between fatty acid composition and clinical status or genotype in cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Nutritional management of cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Potential utility of plasma fatty acid analysis in the diagnosis of cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Oral DHA supplementation in DeltaF508 homozygous cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Is there a case for n-3 fatty acid supplementation in cystic fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Regulation of plasma membrane recycling by CFTR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

A mechanism accounting for the low cellular level of linoleic acid in cystic fibrosis and its reversal by DHA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

The chloride channel blocker anthracene 9-carboxylate inhibits fatty acid incorporation into phospholipid in cultured human airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Lower fetal status of docosahexaenoic acid, arachidonic acid and essential fatty acids is associated with less favorable neonatal neurological condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Consensus report on nutrition for pediatric patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Nutrition in patients with cystic fibrosis: a European Consensus

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

High-performance liquid chromatography/electrospray ionization ion-trap tandem mass spectrometric analysis and quantification of phosphatidylcholine molecular species in the serum of cystic fibrosis subjects supplemented with docosahexaenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1203%2FPDR.0B013E3181B4E8D3

10.1203/PDR.0B013E3181B4E8D3

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

15 September 2017

1013457266

0 references

1 reference